APA (7th ed.) Citation

Zeng, Y., Zhang, X., Lin, D., Feng, X., Liu, Y., Fang, Z., . . . Jiang, L. (2021). A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia. Journal of Hematology & Oncology, 14(1), 1. https://doi.org/10.1186/s13045-021-01199-8

Chicago Style (17th ed.) Citation

Zeng, Yunxin, et al. "A Lysosome-targeted Dextran-doxorubicin Nanodrug Overcomes Doxorubicin-induced Chemoresistance of Myeloid Leukemia." Journal of Hematology & Oncology 14, no. 1 (2021): 1. https://doi.org/10.1186/s13045-021-01199-8.

MLA (9th ed.) Citation

Zeng, Yunxin, et al. "A Lysosome-targeted Dextran-doxorubicin Nanodrug Overcomes Doxorubicin-induced Chemoresistance of Myeloid Leukemia." Journal of Hematology & Oncology, vol. 14, no. 1, 2021, p. 1, https://doi.org/10.1186/s13045-021-01199-8.